Breast Cancer Research | Most Viewed

Submit a manuscript Register

Explore journal

Articles

Display/download options Articles per page: 25 | 50 | 100

Display options

Editor's summary Citation

Download options

Send
To

	All
	1. 1415 Accesses	Editorial Do fatty breasts increase or decrease breast cancer risk? John A Shepherd, Karla Kerlikowske Breast Cancer Research 2012, 14:102 (25 January 2012) Abstract \| Full text \| PDF \| PubMed
	2. 1251 Accesses	Research article Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge Breast Cancer Res 2004, 6:R149-R156 (17 February 2004) Abstract \| Full text \| PDF \| Cited on BioMed Central
	3. 1201 Accesses	Review Epithelial-mesenchymal transition, cancer stem cells and treatment resistance Bhuvanesh Dave, Vivek Mittal, Nicholas M Tan, Jenny C Chang Breast Cancer Research 2011, 14:202 (19 January 2012) Abstract \| Full text \| PDF
	4. 1175 Accesses	Research article Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells Sabine Kasimir-Bauer, Oliver Hoffmann, Diethelm Wallwiener, Rainer Kimmig, Tanja Fehm Breast Cancer Research 2012, 14:R15 (20 January 2012) Abstract \| Provisional PDF \| PubMed
	5. 1150 Accesses	Research article Long-term prognosis of breast cancer detected by mammography screening or other methods Tiina Lehtimäki, Mikael Lundin, Nina Linder, Harri Sihto, Kaija Holli, Taina Turpeenniemi-Hujanen, Vesa Kataja, Jorma Isola, Heikki Joensuu, Johan Lundin Breast Cancer Research 2011, 13:R134 (28 December 2011) Abstract \| Full text \| PDF \| PubMed \| 1 comment \| Editor’s summary Patients with breast cancer detected in mammography screening have a more favorable prognosis than those diagnosed outside a screening program and this should be taken into account in order to avoid over-treatment of screen-detected patients.
	6. 1117 Accesses	Research article MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7 Seok-Jun Kim, Ji-Young Shin, Kang-Duck Lee, Young-Ki Bae, Ki Sung, Seok Nam, Kyung-Hee Chun Breast Cancer Research 2012, 14:R14 (18 January 2012) Abstract \| Full text \| PDF \| PubMed \| Editor’s summary MicroRNA let-7a binds directly to the 3'UTR of C-C chemokine receptor type 7 (CCR7), blocking its protein expression and suppressing migration and invasion of breast cancer cells.
	7. 1037 Accesses	Review Mouse models of breast cancer metastasis Anna Fantozzi, Gerhard Christofori Breast Cancer Research 2006, 8:212 (26 July 2006) Abstract \| Full text \| PDF \| PubMed
	8. 1020 Accesses	Research article Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study François-Clément Bidard, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Paul Cottu, Philippe Beuzeboc, Emilie Rolland, Claire Mathiot, Jean-Yves Pierga Breast Cancer Research 2012, 14:R29 (13 February 2012) Abstract \| Provisional PDF \| Editor’s summary Circulating tumor cell count shows no clear superiority over serum markers for predicting progression-free survival in metastatic breast cancer.
	9. 972 Accesses	Research article Breast asymmetry and predisposition to breast cancer Diane Scutt, Gillian A Lancaster, John T Manning Breast Cancer Research 2006, 8:R14 (20 March 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Breast asymmetry could be a predictor of breast cancer, with the relative risk of developing cancer rising with increases in breast volume asymmetry.
	10. 927 Accesses	Research article Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers Desheng Weng, Jeffrey H Penzner, Baizheng Song, Shigeo Koido, Stuart K Calderwood, Jianlin Gong Breast Cancer Research 2012, 14:R18 (25 January 2012) Abstract \| Provisional PDF \| PubMed
	11. 907 Accesses	Research article Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study Gitte V Sorensen, Deirdre P Cronin-Fenton, Henrik T Sorensen, Sinna P Ulrichsen, Lars Pedersen, Timothy L Lash Breast Cancer Research 2012, 14:R21 (3 February 2012) Abstract \| Provisional PDF \| PubMed
	12. 870 Accesses	Research article Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumour-initiating cells Kaiji Hu, Jennifer Law, Abbas Fotovati, Sandra E Dunn Breast Cancer Research 2012, 14:R22 (6 February 2012) Abstract \| Provisional PDF \| PubMed
	13. 859 Accesses	Editorial The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis Oriana E Hawkins, Ann Richmond Breast Cancer Research 2012, 14:103 (26 January 2012) Abstract \| Full text \| PDF \| PubMed
	14. 823 Accesses	Research article Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He, Charles M Perou Breast Cancer Research 2010, 12:R68 (2 September 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	15. 781 Accesses	Research article Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers - role of estrogen receptor and HER2 reactivation Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin M Ward, Xiaoyong Fu, Maria F Botero, Nuala A Healy, Susan G Hilsenbeck, Gail L Phillips, Gary C Chamness, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff Breast Cancer Research 2011, 13:R121 (28 November 2011) Abstract \| Provisional PDF \| PubMed \| Editor’s summary Combined lapatinib and trastuzumab therapy may improve outcomes in patients with human epidermal growth factor 2 (HER2)-positive breast cancer; adding estrogen receptor inhibition may be optimal in some patients.
	16. 713 Accesses	Editorial Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer? José Pérez-García, Javier Cortés Breast Cancer Research 2012, 14:104 (31 January 2012) Abstract \| Full text \| PDF \| PubMed
	17. 708 Accesses	Short communication Next-generation sequencing Jorge S Reis-Filho Breast Cancer Research 2009, 11(Suppl 3):S12 (18 December 2009) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	18. 702 Accesses	Research article Contribution of CXCL12 secretion to invasion of breast cancer cells Pamela J Boimel, Tatiana Smirnova, Zhen Ni Zhou, Jeffrey Wyckoff, Hae In Park, Salvatore J Coniglio, Purvi Patel, Bin-Zhi Qian, E RICHARD Stanley, Anne R Bresnick, Dianne Cox, Jeffrey W Pollard, William J Muller, John Condeelis, Jeffrey E Segall Breast Cancer Research 2012, 14:R23 (7 February 2012) Abstract \| Provisional PDF \| PubMed
	19. 678 Accesses	Research article CD44⁺/CD24^-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Carol Sheridan, Hiromitsu Kishimoto, Robyn K Fuchs, Sanjana Mehrotra, Poornima Bhat-Nakshatri, Charles H Turner, Robert Goulet, Sunil Badve, Harikrishna Nakshatri Breast Cancer Research 2006, 8:R59 (24 October 2006) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	20. 670 Accesses	Review Breast cancer cell lines: friend or foe? Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs Breast Cancer Res 2003, 5:89-95 (3 February 2003) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	21. 669 Accesses	Research article Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement Hatef Darabi, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, Keith Humphreys Breast Cancer Research 2012, 14:R25 (7 February 2012) Abstract \| Provisional PDF \| PubMed
	22. 653 Accesses	Research article Germline DNA copy number variation in familial and early-onset breast cancer Ana C V Krepischi, Maria Isabel W Achatz, Erika M M Santos, Silvia S Costa, Bianca C G Lisboa, Helena Brentani, Tiago M Santos, Amanda Goncalves, Amanda F Nobrega, Peter L Pearson, Angela M Vianna-Morgante, Dirce M Carraro, Ricardo R Brentani, Carla Rosenberg Breast Cancer Research 2012, 14:R24 (7 February 2012) Abstract \| Provisional PDF \| PubMed
	23. 651 Accesses	Research article PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups Magdalena Cizkova, Aurelie Susini, Sophie Vacher, Geraldine Cizeron-Clairac, Catherine Andrieu, Keltouma Driouch, Emmanuelle Fourme, Rosette Lidereau, Ivan Bieche Breast Cancer Research 2012, 14:R28 (13 February 2012) Abstract \| Provisional PDF
	24. 624 Accesses	Research article Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women Juncheng Dai, Zhibin Hu, Yue Jiang, Hao Shen, Jing Dong, Hongxia Ma, Hongbing Shen Breast Cancer Research 2012, 14:R17 (23 January 2012) Abstract \| Provisional PDF \| PubMed
	25. 622 Accesses	Research article Lack of EGFR activating mutations in European patients with triple negative breast cancer could emphasize geographic and ethnic variations in breast cancer mutation profiles William Jacot, Evelyne Lopez-Crapez, Simon Thezenas, Romain Senal, Frederic Fina, Frederic Bibeau, Gilles Romieu, Pierre-Jean Lamy Breast Cancer Research 2011, 13:R133 (22 December 2011) Abstract \| Provisional PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Potential geographic and ethnic variations in the prevalence of EGFR mutations in triple negative breast cancer have implications for clinical trial design for anti-estrogen growth factor receptor (EGFR) therapies.